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1.1 Combining experience and enterprise
The general backdrop in the management of Chronic Obstructive Pulmonary 
Disease (COPD) has remarkably transformed in the past two decades. Gone is the 
erstwhile nihilistic outlook of COPD as this is replaced by fresh optimism in the 
approach to curtailing the disease [1]. Among the newer developments in recent 
years that led to increased alacrity in confronting a disease that continues to defy 
efforts aimed at reducing its morbidity and mortality is the recognition that people 
all around the globe can play significant roles in reducing the COPD disease burden 
[2]. Leading the charge in this global enterprise are, quite expectedly, the front-
line healthcare professionals who are bearing the load of caring for multitudes of 
patients suffering from the disease. Undaunted by the inundation of challenges 
posed by this disease, clinicians have been energized to assume additional roles 
over and above their duty of care. Many experienced and leading clinicians have 
gathered together multi-disciplinary local and international organizations that 
contribute to the advocacy, research, education, and development of clinical prac-
tice guidelines on COPD. The recent trend of identifying and managing “treatable 
traits” in respiratory disease is a prime example of initiatives started by experienced 
pulmonologists that led to major cooperation and knowledge transfer, resulting in 
major paradigm shifts in the management of COPD. Identifying a simple biomarker 
like peripheral eosinophilia that is related to important clinical events such as exac-
erbation rates and is responsive to treatment with steroids has had major impact on 
symptoms and progression of the disease.
Another potential contribution from experienced clinicians in the field of 
respiratory medicine is in the exponential development of digital technologies in 
Respiratory Medicine. For the novice in medical technology, the following are broad 
categories of digital development in the field of respiratory medicine:
1. Telemedicine – this includes tele-consultation, tele-monitoring and  
tele-rehabilitation, all increasing in demand with the current pandemic
2. Artificial Intelligence (AI) – current uses include Google AI that has been 
shown to be as good as or better in diagnosing/predicting lung cancer using 
screening CT scans than traditional reporting by radiologists. Google Aug-
mented Reality (AR) microscope also are less likely to miss cancer diagnosis, 
reducing the workload of pathologists
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3. Digital diagnosis – software systems that provide diagnosis of medical  
conditions using available information without human doctors
4. Equipment software – mobile health or m-health, the practice of medicine or 
public health supported by mobile devices
5. Medical robotics – including use of virtual reality & mixed reality that allows 
interaction with the user (e.g. surgeons during procedures)
6. Others e.g. Biosensors & electronic health records
Clinicians need to prepare for the brave new world of digital medicine. Having 
acquired decades of experience with “real-world” challenges in their specialty, 
experienced health professionals stand in good stead as mediators between the 
technological industry and patients’ needs and desires. We should be the ones 
providing this link in order to protect the interests of patients from inappropri-
ate use of digital technology developed by PHD scientists without the benefit of 
prolonged interaction with patients. While we face the looming prospect of digital 
technology one day replacing the role of human doctors, experienced physicians 
should meanwhile embrace our intermediary role in helping scientists perfect their 
scientific developments while guiding patients on the use of digital technologies for 
the betterment of their health. For the benefit of patients, we should seek to keep 
abreast with digital medicine and not be overwhelmed by the technological tide or 
leave clinical decision-making solely between patients and tech providers. Unlike 
technologists and their machines, we as physicians have to a vow to keep – to always 
put our patients’ best interests first.
2. Knowledge transfer during pandemic
COPD is one major disease that is multifactorial in pathogenesis and affects 
multiple bodily systems in such ways that multi-disciplinary collaboration is inevi-
table and often essential in delivering optimal care to its sufferers. At the beginning 
of a new decade when the world is ravaged by an unforeseen pandemic caused by 
the Coronavirus COVID-19, alliance of stake-holders in COPD is more essential 
than ever before. The reliance on technology in order to reduce physical human-
to-human contact can either prove to be a boon or bane to closer cooperation to 
improve patient care. As the world grapples with an unwelcome novel lung infec-
tion, we cannot afford to ignore the incessant impact of a disease that continues to 
kills more people annually than all respiratory tract infections combined (inclu-
sive of those related to coronavirus COVID-19, accurate at the time of writing). 
Knowledge transfer is imperative in fighting any disease new or old and sharing 
essential medical information quickly is crucial.
It is time for a new paradigm in tackling the age-old disease of COPD. No longer 
can stake-holders afford to research or treat this disorder in the isolation of ‘ivory-
tower’ institutions. The expected shift in the locus of disease burden to the Majority 
World urgently requires contextualization of medical progress to suit local environ-
ment and habits [3]. Continuing contributions from international intelligentsia and 
academic sources will be helpful in developing a wider perspective of the approach 
to this common global disease, as well as provide clinicians everywhere an updated 
reference for the management of this malady.
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